Key features and details
- Rabbit polyclonal to PR3
- Suitable for: IHC-P
- Reacts with: Mouse, Rat, Human
- Isotype: IgG
Product nameAnti-PR3 antibody
See all PR3 primary antibodies
DescriptionRabbit polyclonal to PR3
Tested applicationsSuitable for: IHC-Pmore details
Species reactivityReacts with: Mouse, Rat, Human
Synthetic peptide within Human PR3 conjugated to Keyhole Limpet Haemocyanin (KLH). The exact sequence is proprietary.
Database link: P24158
- Mouse embryo and Rat brain tissues.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.09% Sodium azide
Constituents: 0.01% BSA, 50% Glycerol
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab202968 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/100 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Use at 1/50 - 1/200 with fluorescent detection methods.
FunctionPolymorphonuclear leukocyte serine protease that degrades elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV (in vitro) and causes emphysema when administered by tracheal insufflation to hamsters.
Sequence similaritiesBelongs to the peptidase S1 family. Elastase subfamily.
Contains 1 peptidase S1 domain.
- Information by UniProt
- ACPA antibody
- AGP 7 antibody
- AGP7 antibody
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Rat brain labeling PR3 with ab202968 at 1/200 dilution followed by conjugation to the secondary antibody and DAB staining.
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Mouse embryo labeling PR3 with ab202968 at 1/200 dilution followed by conjugation to the secondary antibody and DAB staining.
ab202968 has not yet been referenced specifically in any publications.